← back
CVE-2023-22868

IBM Aspera Faspex cross-site scripting

CVSS 5.4 MEDIUMEPSS 0.4%CWE-79
Vexday Risk Score
13Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 5.4EPSS 0.4%KEV nãoPoC Nuclei Metasploit Patch referenciado
Lifecycle
17 Feb 2023Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Affected products
IBM · Aspera Faspex